Literature DB >> 16567230

Hyperthermic syndromes induced by toxins.

Daniel E Rusyniak1, Jon E Sprague.   

Abstract

Normal thermogenesis requires a complex interaction between systems that generate and dissipate heat. Serving as director of thermogenesis, the hypothalamus activates the sympathetic nervous system along with the thyroid and adrenal glands to respond to changes in body temperature. Working in concert, these systems result in heat generation by uncoupling of oxidative phosphorylation, combined with impaired heat dissipation through vasoconstriction. In this article, the authors discuss serotonin and sympathomimetic syndromes, neuroleptic malignant syndrome,and malignant hyperthermia and how these syndromes affect the hypothalamic and sympathetic nervous systems, resulting at times in severe hyperthermia. Current treatment recommendations and future trends in treatment are also discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567230     DOI: 10.1016/j.cll.2006.01.007

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  13 in total

1.  Case report of olanzapine-associated elevation of serum creatine kinase in a 16-year-old boy with heat stroke.

Authors:  Mohammad Jafferany; Jennifer Lowry
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

2.  Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2.

Authors:  Derong Ding; Justin R Nickell; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2015-05-09       Impact factor: 2.823

3.  The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stress.

Authors:  Daniel E Rusyniak; Dmitry V Zaretsky; Maria V Zaretskaia; Pamela J Durant; Joseph A DiMicco
Journal:  Physiol Behav       Date:  2012-02-14

Review 4.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Neurol Clin       Date:  2011-06-24       Impact factor: 3.806

5.  Distribution of temperature changes and neurovascular coupling in rat brain following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") exposure.

Authors:  Daniel Coman; Basavaraju G Sanganahalli; Lihong Jiang; Fahmeed Hyder; Kevin L Behar
Journal:  NMR Biomed       Date:  2015-08-19       Impact factor: 4.044

6.  A rare case of neuroleptic malignant syndrome presenting with serious hyperthermia treated with a non-invasive cooling device: a case report.

Authors:  Christian Storm; Rolf Gebker; Anne Krüger; Lutz Nibbe; Joerg C Schefold; Frank Martens; Dietrich Hasper
Journal:  J Med Case Rep       Date:  2009-02-19

Review 7.  Management of the critically poisoned patient.

Authors:  Jennifer S Boyle; Laura K Bechtel; Christopher P Holstege
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-06-29       Impact factor: 2.953

Review 8.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Psychiatr Clin North Am       Date:  2013-04-11

Review 9.  Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia.

Authors:  Rae R Matsumoto; Michael J Seminerio; Ryan C Turner; Matthew J Robson; Linda Nguyen; Diane B Miller; James P O'Callaghan
Journal:  Pharmacol Ther       Date:  2014-05-14       Impact factor: 12.310

Review 10.  Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicity.

Authors:  Florian Eyer; Thomas Zilker
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.